All subjects had MASH (F2-3 by histology, a body mass index (BMI) of at least 27 kg/m 2 , fat fraction by magnetic resonance imaging-proton density fat fraction (MRI-PDFF) of at least 8%, and liver stiffness measurement (LSM) of at least 8.5 kPa without excess alcohol use
You are overweight or obese, especially if weight gain is worsening blood sugar, cholesterol, blood pressure, fatty liver risk, inflammation, or joint pain
Middeke et al., 1997
Plasma half-life is short (tens of minutes), but tissue effects persist for several hours through a second-messenger cascade
Research suggests GLP-1 users may lose a significant portion of total weight loss as lean mass rather than fat if protein intake is inadequate estimates range from 2540% of weight lost coming from lean tissue without active muscle preservation strategies
To understand whether the GLP-1MK-801 conjugate activates distinct neural circuitries, we used light-sheet microscopy and cFOS immunohistochemistry to obtain quantitative 3D whole-brain activity signatures in response to GLP-1MK-801 and semaglutide dosing (Fig
